Furthermore, a study conducted by Burgdof et al. investigating IGFBP-2’s effects on patients suffering from PTSD demonstrated the effectiveness of intravenous administration of IGFBP-2 in rat models. The gene discussed is IGFBP2; the disease is post-traumatic stress disorder.